The role of systemic corticosteroids when treating infections in adult primary care - 12/06/24
Highlights |
• | Due to their anti-inflammatory properties, systemic corticosteroids are widely used in ambulatory medical practice. |
• | Corticosteroid treatment can be beneficial in some of the infectious disease cases managed in primary care. |
• | When the benefit exists, it remains modest, and the level of evidence concerning the utilization of corticosteroids is low or moderate. In no situation can the indication for corticosteroid therapy be considered official, or even indisputable. |
• | Even during short-term administration at low doses, the immunosuppressive, neurostimulation and metabolic stimulation properties of corticosteroids may be responsible for adverse events. |
Abstract |
Inflammatory response to aggressive infection is responsible not only for symptoms, especially pain, but also for severity, when the inflammatory cascade is violent, and provokes a deleterious cytokine storm.
Due to their anti-inflammatory properties, corticosteroids are widely used in ambulatory medical practice. While their beneficial effects on some symptoms, particularly pain, are undeniable, so are the risks associated with their other properties (immunosuppression, neurostimulation, hypermetabolism), even during short-term administration at low doses.
Following robust risk–benefit assessment, the role of corticosteroids in the treatment of a number of serious pathologies (septic shock, severe acute community-acquired pneumonia, and some forms of bacterial meningitis such as hypoxia-related pneumocystosis, etc.) is presently well-defined. The objective of this review is not to consider the role of corticosteroids in cases of severe infectious disease necessitating hospital-based management, or in contexts where there exists a clear consensus in favor of their utilization.
This work represents an attempt to apprise the current state of knowledge on the interest of corticosteroids in the management of infections in adults in primary care.
Corticosteroid treatment can be beneficial with regard to some of the infectious diseases treated in primary care. That said, when the benefit actually appears, it remains modest, and the level of evidence supporting the utilization of corticosteroids is low or moderate. In no situation is an indication for corticosteroid therapy official or even, at the very least, indisputable.
With regard to the pathologies under consideration, corticosteroid prescription must imperatively be based on impeccable characterization of the clinical situation, diagnosis of severity, knowledge of the disease field, and risk–benefit assessment for a given patient.
Le texte complet de cet article est disponible en PDF.Keywords : Corticosteroid, Infection, Primary care, Respiratory infection, Skin infection
Plan
Vol 54 - N° 4S
Article 104925- juin 2024 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?